Skip to content
Search

Latest Stories

Natural justice demands repayment of Covid costs, says NPA as annual contract negotiations begin

The Pharmaceutical Services Negotiating Committee (PSNC) has announced that formal tripartite negotiations on the arrangements for the Community Pharmacy Contractual Framework (CPCF) in 2021/22 have begun.

It also confirmed that there was still no resolution on the extra costs borne by community pharmacy contractors in England to operate during the Covid-19 pandemic.


Giving his reaction, NPA chair, Andrew Lane, said: “It is massively disappointing that pharmacies are still waiting for a resolution on Covid costs. The prime minister’s warm words about the heroics of pharmacy teams during the pandemic will sound very hollow unless he keeps his promise to reimburse pharmacies for the costs they have incurred to keep vital services running.

“Community pharmacies have kept their side of the bargain – staying open to keep people well, save lives and help the country out of lockdown. In so serving the nation, pharmacies have incurred considerable extra costs that natural justice demands to be repaid.

“The NHS would not have been able to cope over the past 12 months without an accessible network of pharmacies near to where people live, work and shop. We need this sorted quickly, to avoid a collapse in morale and the acceleration of pharmacy closures, he said.

The negotiations announced today are being help behind closed doors between PSNC, the Department of Health and Social Care (DHSC) and NHS England and NHS Improvement (NHSE&I).

The discussions taking place will cover all service, funding and other arrangements for pharmacies in 2021/22, in line with the five-year CPCF deal.

“Alongside this process, separate negotiations on funding to recognise the impact of the Covid-19 pandemic on contractors are also ongoing between PSNC and the Government,” the pharmacy negotiator said.

PSNC chief executive Simon Dukes said: “Contractors have been waiting many months for news on Covid-19 funding and on the CPCF for 2021-22 (Year 3 of our five-year deal) and it is frustrating that we are yet again beginning to negotiate CPCF arrangements in-year.

“Contractors who have been following our negotiations updates will know what we are up against – PSNC has already rejected one government offer on Covid costs, and we received no response to our autumn bid for a broader funding uplift. I have talked of the blocks we repeatedly face-with officials challenging us on costs at every step and refusing to reward us based on the value we deliver- and despite the phenomenal efforts of pharmacies in the past year, I do not expect these negotiations to be any easier.

“The PSNC Committee is deeply concerned about the lack of resolution on Covid costs and they are worried about workload and finances in the year ahead: we will do all that we can to make this as manageable as possible for contractors.

“The Committee has also made clear to HM Government that while we will now commence negotiations, it is unlikely to be able to make any final decision on the CPCF until we have clarity on Covid costs: resolving these costs has been urgent for many months, and contractors’ questions must be answered and a satisfactory deal reached before we can move any further forwards on other matters.”

More For You

The new funding uplift our commitment to rebuilding the sector: Kinnock
The new funding uplift our commitment to rebuilding the sector: Kinnock
Health minister Stephen Kinnock

Community pharmacy to play "big role" in NHS 10-year Health Plan, says Kinnock

Pharmacy minister Stephen Kinnock has insisted that community pharmacy have an integral part to play in the government’s long-term plan to refocus healthcare from hospitals to the community.

Through the new NHS 10-Year Plan, the government aims to transform the NHS by shifting from hospital to community, analogue to digital, and sickness to prevention.

Keep ReadingShow less
AAH Pharmaceuticals introduces 20 new electric vans to its delivery fleet

18 vans have been added to the AAH DC in Ruislip, and another 2 to their branch in Glasgow

Photo credit: AAH

AAH Pharmaceuticals adds 20 new electric vans to reduce carbon emissions

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced 20 new electric vans to its delivery fleet, marking a significant step forward in its Carbon Reduction Plan, which is aligned to the NHS net zero targets.

Eighteen of the new electric vehicles have been deployed at the AAH distribution centre in Ruislip, with the remaining two now in operation at its Glasgow branch.

Keep ReadingShow less
Operation Subaru:

Some of the medicines seized in raids today. Credit: MHRA

12 arrested in MHRA’s biggest medicines trafficking crackdown

Twelve people have been arrested in a series of dawn raids across the West Midlands and the Northwest of England today (29 April), as part of the biggest criminal investigation ever undertaken by the Medicines and Healthcare products Regulatory Agency (MHRA) into organised medicines trafficking.

The suspects were detained on suspicion of involvement in organised crime, conspiracy to sell or supply controlled and unlicensed medicines, and money laundering.

Keep ReadingShow less
Sukhi Basra named NPA vice-chair in historic leadership update with Olivier Picard as new chair

Olivier Picard steps up as NPA chair, Basra as vice-chair

Olivier Picard named new NPA chair

The National Pharmacy Association (NPA) has announced Olivier Picard as the organisation’s new chair.

Picard replaces Nick Kaye whose term comes to an end this week.

Keep ReadingShow less
 RPS honours Professor Tony Avery OBE for excellence in prescribing safety and patient care

Professor Tony Avery OBE

Pic credit: RPS

Professor Tony Avery OBE awarded RPS Honorary Fellowship

The Royal Pharmaceutical Society (RPS) Assembly has awarded an Honorary Fellowship to Professor Tony Avery OBE in recognition of his outstanding contribution to prescribing safety and patient care.

The Honorary Fellowship is given to those who are not eligible for membership of the Society but have either attained a distinction in a particular aspect or aspects of pharmacy, made a distinctive contribution to pharmacy or the RPS, distinguished themselves in any branches of knowledge referred to in the objects of the Society or achieved eminence in public life.

Keep ReadingShow less